A detailed history of Moody National Bank Trust Division transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Moody National Bank Trust Division holds 36,233 shares of BMY stock, worth $2.09 Million. This represents 0.2% of its overall portfolio holdings.

Number of Shares
36,233
Previous 33,115 9.42%
Holding current value
$2.09 Million
Previous $1.38 Million 36.36%
% of portfolio
0.2%
Previous 0.11%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 03, 2024

BUY
$39.66 - $51.75 $123,659 - $161,356
3,118 Added 9.42%
36,233 $1.88 Million
Q2 2024

Jul 03, 2024

BUY
$40.25 - $52.99 $20,567 - $27,077
511 Added 1.57%
33,115 $1.38 Million
Q1 2024

Apr 04, 2024

SELL
$47.98 - $54.4 $13,866 - $15,721
-289 Reduced 0.88%
32,604 $1.77 Million
Q4 2023

Jan 11, 2024

SELL
$48.48 - $57.85 $1.34 Million - $1.6 Million
-27,632 Reduced 45.65%
32,893 $1.69 Million
Q3 2023

Oct 12, 2023

BUY
$57.89 - $64.73 $269,420 - $301,253
4,654 Added 8.33%
60,525 $3.51 Million
Q2 2023

Jul 07, 2023

SELL
$63.71 - $70.74 $20,642 - $22,919
-324 Reduced 0.58%
55,871 $3.57 Million
Q1 2023

Apr 19, 2023

BUY
$65.71 - $74.53 $25,035 - $28,395
381 Added 0.68%
56,195 $3.89 Million
Q4 2022

Jan 11, 2023

BUY
$68.48 - $81.09 $70,260 - $83,198
1,026 Added 1.87%
55,814 $4.02 Million
Q3 2022

Oct 05, 2022

BUY
$0.13 - $76.84 $683 - $403,947
5,257 Added 10.61%
54,788 $3.9 Million
Q2 2022

Jul 07, 2022

BUY
$72.62 - $79.98 $778,994 - $857,945
10,727 Added 27.64%
49,531 $3.81 Million
Q1 2022

Apr 12, 2022

SELL
$61.48 - $73.72 $246,411 - $295,469
-4,008 Reduced 9.36%
38,804 $2.83 Million
Q4 2021

Jan 13, 2022

SELL
$53.63 - $62.52 $3.36 Million - $3.92 Million
-62,676 Reduced 59.42%
42,812 $2.67 Million
Q3 2021

Oct 07, 2021

SELL
$59.17 - $69.31 $6,212 - $7,277
-105 Reduced 0.1%
105,488 $6.24 Million
Q2 2021

Jul 13, 2021

SELL
$61.91 - $67.42 $9,286 - $10,113
-150 Reduced 0.14%
105,593 $7.06 Million
Q1 2021

Apr 14, 2021

BUY
$59.34 - $66.74 $20,769 - $23,359
350 Added 0.33%
105,743 $6.68 Million
Q4 2020

Mar 04, 2021

BUY
$57.74 - $65.43 $188,116 - $213,170
3,258 Added 3.19%
105,393 $6.54 Million
Q3 2020

Oct 08, 2020

BUY
$57.43 - $63.64 $12,290 - $13,618
214 Added 0.21%
102,135 $6.16 Million
Q2 2020

Jul 10, 2020

BUY
$54.82 - $64.09 $46,103 - $53,899
841 Added 0.83%
101,921 $5.99 Million
Q1 2020

Apr 17, 2020

BUY
$46.4 - $67.43 $7,192 - $10,451
155 Added 0.15%
101,080 $5.63 Million
Q4 2019

Jan 28, 2020

BUY
$49.21 - $64.19 $4.36 Million - $5.68 Million
88,537 Added 714.7%
100,925 $6.48 Million
Q3 2019

Oct 18, 2019

BUY
$42.77 - $50.71 $299,903 - $355,578
7,012 Added 130.43%
12,388 $628,000
Q2 2019

Jul 22, 2019

SELL
$44.62 - $49.34 $28,779 - $31,824
-645 Reduced 10.71%
5,376 $244,000
Q1 2019

Apr 11, 2019

SELL
$45.12 - $53.8 $8,617 - $10,275
-191 Reduced 3.07%
6,021 $288,000
Q4 2018

Jan 07, 2019

BUY
$48.76 - $63.23 $51,783 - $67,150
1,062 Added 20.62%
6,212 $323,000
Q3 2017

Oct 12, 2017

BUY
$55.23 - $63.74 $284,434 - $328,261
5,150
5,150 $328,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $123B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Moody National Bank Trust Division Portfolio

Follow Moody National Bank Trust Division and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Moody National Bank Trust Division, based on Form 13F filings with the SEC.

News

Stay updated on Moody National Bank Trust Division with notifications on news.